EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A risk science perspective on vaccines

Ingrid Glette-Iversen, Terje Aven, Roger Flage iD

Risk Analysis · 2024

DOI: 10.1111/risa.14228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Risk Analysis, 2024. Verfasst von Ingrid Glette-Iversen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Safety, Economics and Planning, University of Stavanger, Stavanger, Norway. Hauptthemen laut MEDLINE: Risk Assessment, Vaccination, Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccines can be seen as one of the greatest successes in modern medicine. Good examples are the vaccines against smallpox, polio, and measles. Unfortunately, vaccines can have side effects, but the risks are considered by the health authorities and experts to be small compared to their benefits. Nevertheless, there are many who are skeptical of vaccination, something which has been very clearly demonstrated in relation to the COVID‐19 disease. Risk is the key concept when evaluating a vaccine, in relation to both its ability to protect against the disease and its side effects. However, risk is a challenging concept to measure, which makes communication about vaccines’ performance and side effects difficult. The present article aims at providing new insights into vaccine risks—the understanding, perception, communication, and handling of them—by adopting what is here referred to as a contemporary risk science perspective. This perspective clarifies the relationships between the risk concept and terms like uncertainty, knowledge, and probability. The skepticism toward vaccines is multifaceted, and influenced by concerns that extend beyond the effectiveness and safety of the vaccines. However, by clarifying the relationships between key concepts of risk, particularly how uncertainty affects risk and its characterization, we can improve our understanding of this issue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Risk AssessmentVaccinationVaccinesHumansCOVID-19COVID-19 VaccinesPandemicsUncertainty

Stichwörter der Autor:innen

decision‐makingrisk characterizationrisk communicationvaccination riskvaccine risk

Substanzen

COVID-19 VaccinesVaccines

Autor:innen und Institutionen

  • Department of Safety, Economics and Planning, University of Stavanger, Stavanger, Norway.

ORCID-Profile: Roger Flage

Zitieren

APA

Glette-Iversen, I., Aven, T., & Flage, R. (2024). A risk science perspective on vaccines. Risk Analysis. https://doi.org/10.1111/risa.14228

Vancouver

Glette-Iversen I, Aven T, Flage R. A risk science perspective on vaccines. Risk Analysis. 2024. doi:10.1111/risa.14228

BibTeX
@article{GletteIversen2024,
  author = {Glette-Iversen, Ingrid and Aven, Terje and Flage, Roger},
  title = {A risk science perspective on vaccines},
  journal = {Risk Analysis},
  year = {2024},
  doi = {10.1111/risa.14228}
}
Kostenlos starten →